心臓モニタリング&心調律管理デバイスの世界市場予測:CM別、CRM別、エンドユーザー別...市場調査レポートについてご紹介

【英文タイトル】Cardiac Monitoring & Cardiac Rhythm Management Devices Market CM (ECG, ILR, Event Monitors, MCT), CRM (Defibrillator (ICD (CRT D), External Defibrillators (AED)), Pacemaker (CRT P, Dual Chamber Pacemaker)), End User (Hospitals) - Global Forecast to 2024

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Introduction (Page No. – 21)
1.1 Objectives of The Study
1.2 Market Definition
1.3 Markets Covered
1.4 Years Considered for The Study
1.5 Currency
1.6 Limitations
1.7 Stakeholders
2 Research Methodology (Page No. – 25)
2.1 Research Data
2.2 Secondary Data
2.2.1 Key Data From Secondary Sources
2.3 Primary Data
2.3.1 Key Data From Primary Sources
2.4 Market Size Estimation
2.4.1 Revenue Mapping-Based Market Estimation
2.5 Data Triangulation
2.5.1 Assumptions for The Study
2.5.2 Research Limitations
3 Executive Summary (Page No. – 34)
4 Premium Insights (Page No. – 38)
4.1 Cardiac Monitoring and Cardiac Rhythm Management Devices: Market Overview
4.2 Asia Pacific: Cardiac Monitoring and Cardiac Rhythm Management Devices Market Share, By End User & Country (2018)
4.3 Cardiac Rhythm Management Devices Market, By Type (2017–2024)
4.4 Geographic Snapshot of The Cardiac Monitoring and Cardiac Rhythm Management Devices Market
5 Market Overview (Page No. – 42)
5.1 Introduction
5.2 Market Dynamics: Drivers, Restraints, and Challenges
5.2.1 Drivers
5.2.1.1 Increasing Incidence of Cardiovascular Disease
5.2.1.2 Technological Advancements
5.2.1.3 Increasing Investments, Funds, and Grants for Research on CM & CRM Devices
5.2.1.4 Growing Preference for Wearable Cardiac Devices
5.2.2 Restraints
5.2.2.1 Increasing Incidence of Cied Infections
5.2.3 Challenges
5.2.3.1 Dearth of Skilled Professionals With Expertise in Electrocardiography and Cardiac Rhythm Management Devices
5.2.3.2 Frequent Product Recalls
6 Cardiac Monitoring Devices Market, By Type (Page No. – 47)
6.1 Introduction
6.2 Ecg Devices
6.2.1 Resting Ecg Devices
6.2.1.1 Low Cost, Ease of Use, and Simplicity Have Driven The Adoption of Resting Ecg Devices
6.2.2 Stress Ecg Devices
6.2.2.1 Flexibility in Use has Driven The Demand for Stress Ecg Devices, But High Cost has Negatively Affected The Market
6.2.3 Holter Monitors
6.2.3.1 Short Duration of Monitoring is A Key Restraint to Market Growth
6.3 Implantable Loop Recorders
6.3.1 High Cost and Limited Applications Have Hindered Demand Growth
6.4 Mobile Cardiac Telemetry Devices
6.4.1 Increasing Demand for Cardiac Monitoring Solutions in Home Care Settings is Propelling Market Growth
6.5 Cardiac Output Monitoring Devices
6.5.1 Increasing Number of Cardiac Surgeries Will Drive The Demand for Com Devices
6.6 Event Monitors
6.6.1 Event Monitors Market, By Type
6.6.1.1 Pre-Symptom Event Monitors
6.6.1.1.1 Large Storage Capacity of Pre-Symptom Event Monitors Makes Them Ideal for Long-Term Monitoring
6.6.1.2 Post-Symptom Event Monitors
6.6.1.2.1 Emergence of Handheld, Wireless, and Remote Monitors Will Drive Market Growth
6.6.2 Event Monitors Market, By Technology
6.6.2.1 Autodetect Monitors
6.6.2.1.1 Autodetect Monitors are Ideal for Patients Who are Unable to Reliably Trigger Monitors
6.6.2.2 Manual Event Monitors
6.6.2.2.1 Manual Monitors Can Be Pre-Symptom Or Post-Symptom, But Rely on The Patient to Be Triggered
6.7 Smart Ecg Monitors
6.7.1 Lack of Data Security Hinders The Growth of The Smart Monitors Market to Some Extent
7 Cardiac Rhythm Management Devices Market, By Type (Page No. – 62)
7.1 Introduction
7.2 Defibrillators
7.2.1 Implantable Cardioverter Defibrillators
7.2.1.1 Transvenous Implantable Cardioverter Defibrillators (T-Icds)
7.2.1.1.1 Biventricular Implantable Cardioverter Defibrillators/Cardiac Resynchronization Therapy Defibrillators
7.2.1.1.1.1 Biventricular Icds/Crt-Ds are Preferred for Heart Failure Patients
7.2.1.1.2 Dual-Chamber Implantable Cardioverter Defibrillators
7.2.1.1.2.1 Benefits of Dual-Chamber Icds, Such as Higher Diagnostic Accuracy, Make Them Ideal for Patients With Tachycardia Episodes
7.2.1.1.3 Single-Chamber Implantable Cardioverter Defibrillators
7.2.1.1.3.1 Launch of Mri-Compatible Single-Chamber Icds Will Drive Market Growth
7.2.1.2 Subcutaneous Implantable Cardioverter Defibrillators
7.2.1.2.1 Safety and Efficacy of S-Icds in The Prevention of Sudden Cardiac Arrest Will Boost Their Adoption
7.2.2 External Defibrillators
7.2.2.1 Automated External Defibrillators
7.2.2.1.1 Semi-Automated External Defibrillators
7.2.2.1.1.1 Semi-Automated External Defibrillators Accounted for The Largest Share of The Aeds Market in 2018
7.2.2.1.2 Fully Automated External Defibrillators
7.2.2.1.2.1 Benefits of Fully Automatic Aeds and Higher Accuracy Will Drive Market Growth
7.2.2.2 Manual External Defibrillators
7.2.2.2.1 North America Dominates The Manual Defibrillators Market
7.2.2.3 Wearable Cardioverter Defibrillators
7.2.2.3.1 Ease of Use and The Noninvasive Nature of Wearable Cardioverter Defibrillators Will Support Market Growth
7.3 Pacemakers
7.3.1 Pacemakers Market, By Implantability
7.3.1.1 Implantable Pacemakers
7.3.1.1.1 Introduction of Leadless and Mri-Safe Devices has Boosted Device Popularity
7.3.1.2 External Pacemakers
7.3.1.2.1 Increasing Number of Open-Heart Surgeries Will Drive The Demand for External Pacemakers
7.3.2 Pacemakers Market, By Type
7.3.2.1 Dual-Chamber Pacemakers
7.3.2.1.1 Dual-Chamber Pacemakers are The Most Commonly Implanted Pacemakers for Bradycardia—A Key Factor Driving Market Growth
7.3.2.2 Single-Chamber Pacemakers
7.3.2.2.1 Introduction of Leadless Pacemakers Will Stimulate Demand in This Product Segment
7.3.2.3 Biventricular/Crt Pacemakers
7.3.2.3.1 High Cost and Unfavorable Reimbursement Scenario Have Hindered Market Growth
8 Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By End User (Page No. – 82)
8.1 Introduction
8.2 Hospitals, Clinics, & Cardiac Centers
8.2.1 Growing Number of Cardiac Implant Procedures to Drive Market Growth
8.3 Ambulatory Surgery Centers
8.3.1 Growing Number of Ascs in The US to Drive The Adoption of CM & CRM Devices
8.4 Other End Users
9 Cardiac Monitoring and Cardiac Rhythm Management Devices Market, By Region (Page No. – 89)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 Growing Number of Fda Approvals for CM & CRM Devices to Support Market Growth in The US
9.2.2 Canada
9.2.2.1 Growing Focus of Government and Private Organizations on Providing Funding for Research to Drive Market Growth
9.3 Europe
9.3.1 Germany
9.3.1.1 Increasing Healthcare Expenditure to Drive Market Growth
9.3.2 France
9.3.2.1 Rising Prevalence of Heart Failure to Drive The Adoption of Crt Devices in France
9.3.3 UK
9.3.3.1 Rising Demand for Home-Based Cardiac Monitoring Devices to Support Market Growth
9.3.4 Italy
9.3.4.1 Increasing Incidence of Atrial Fibrillation Among The Elderly Will Drive Market Growth in Italy
9.3.5 Spain
9.3.5.1 Rising Awareness and Growing Device Adoption Indicate Strong Growth in The Coming Years
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.1.1 High Healthcare Expenditure and Favorable Reimbursement and Insurance Coverage to Support Market Growth in Japan
9.4.2 China
9.4.2.1 Rising Prevalence of Cvds and Government Support for Infrastructural Improvements Will Drive Market Growth
9.4.3 India
9.4.3.1 Government Initiatives Will Propel Market Growth in India
9.4.4 Rest of Asia Pacific
9.5 Rest of The World
10 Competitive Landscape (Page No. – 135)
10.1 Overview
10.2 Market Share Analysis, 2018
10.3 Competitive Scenario
10.3.1 Contracts, Partnerships, & Agreements (2016–2019)
10.3.2 Product Launches & Approvals (2016–2019)
10.3.3 Expansions (2016–2019)
10.3.4 Acquisitions (2016–2019)
10.4 Competitive Leadership Mapping (2019)
10.4.1 Vendor Inclusion Criteria
10.4.2 Visionary Leaders
10.4.3 Dynamic Differentiators
10.4.4 Emerging Companies
11 Company Profiles (Page No. – 140)
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 Abbott Laboratories
11.2 Medtronic, PLC
11.3 Boston Scientific Corporation
11.4 GE Healthcare
11.5 Koninklijke Philips N.V.
11.6 Biotronik
11.7 Asahi Kasei Corporation
11.8 Microport Scientific Corporation
11.9 Hill-Rom Holdings
11.1 Nihon Kohden Corporation
11.11 Schiller
11.12 Biotelemetry
11.13 ACS Diagnostics
11.14 BPL Medical Technologies
11.15 BTL
11.16 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
11.17 Lepu Medical Technology
11.18 Shree Pacetronix
11.19 Osypka AG
11.2 Alivecor, Inc.
*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.
12 Appendix (Page No. – 179)
12.1 Discussion Guide
12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.3 Available Customizations
12.4 Related Reports
12.5 Author Details


【レポート販売概要】

■ タイトル:心臓モニタリング&心調律管理デバイスの世界市場予測:CM別、CRM別、エンドユーザー別
■ 英文:Cardiac Monitoring & Cardiac Rhythm Management Devices Market CM (ECG, ILR, Event Monitors, MCT), CRM (Defibrillator (ICD (CRT D), External Defibrillators (AED)), Pacemaker (CRT P, Dual Chamber Pacemaker)), End User (Hospitals) - Global Forecast to 2024
■ 発行日:2019年10月30日
■ 調査会社:MarketsandMarkets
■ 商品コード:MD1038
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。